Top investor castigates Unilever after failed £50bn bid for GSK arm - The Guardian

← Go back Jan 01, 2022

A leading Unilever shareholder has called the companys failed £50bn offer for GSKs consumer healthcare division a near-death experience and said management should focus on improving its core business…

Read more: The Guardian

Chat with us!
We are very happy to share our knowledge with you, please enter some details so we know that you is really you.